The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis
Open accessAbstract
There is growing evidence of activated microglia and inflammatory processes in the cerebral cortex in amyotrophic lateral sclerosis (ALS). Activated microglia is characterized by increased expression of the 18 kDa translocator protein (TSPO) in the brain and may be a useful biomarker of inflammation. In this study, we evaluated neuroinflammation in ALS patients using a radioligand of TSPO, (18)F-DPA-714. Ten patients with probable or definite ALS (all right-handed, without dementia, and untreated by riluzole or other medication that might bias the binding on the TSPO), were enrolled prospectively and eight healthy controls matched for age underwent a PET study. Comparison of the distribution volume ratios between both groups were performed using a Mann-Whitney's test. Significant increase of distribution of volume ratios values corresponding to microglial activation was found in the ALS sample in primary motor, supplementary motor and temporal cortex (p = 0.009, p = 0.001 and p = 0.004, respectively). These results suggested that the cortical uptake of (18)F-DPA-714 was increased in ALS patients during the "time of diagnosis" phase of the disease. This finding might improve our understanding of the pathophysiology of ALS and might be a surrogate marker of efficacy of treatment on microglial activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“presumably due to increased CNS microglia or their activation, as suggested by positron emission tomography (PET) imaging using radiotracers specific for activated microglia [423,424].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [423]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
The FAB: A frontal assessment battery at bedside
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
Pochet, P. (2006) · Griffith Research Online · Cited by 1,550
Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J.-J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M.-R., et al. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.06.005 · Cited by 1,389
UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Prevalence and patterns of cognitive impairment in sporadic ALS
Ringholz, G. M., Appel, S. H., Bradshaw, M. R., Cooke, N., Mosnik, D. M., & Schulz, P. E. (2005) · Neurology · doi:10.1212/01.wnl.0000172911.39167.b6 · Cited by 843
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- I Bertrand, 1925, La sclérose latérale amyotrophique (Anatomie pathologique), RevNeurol, 1, 779
Cited by
Sorted by citations
Hardiman, O. M., Al‐Chalabi, A., Chiò, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.71 · Cited by 2,262
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Mejzini, R., Flynn, L. L., Pitout, I. L., Fletcher, S., Wilton, S. D., & Akkari, P. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01310 · Cited by 803
Liu, J., & Wang, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01005 · Cited by 376
Inflammation in ALS/FTD pathogenesis
McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 341
RETRACTED: Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases
Rauf, A., Badoni, H., Abu‐Izneid, T., Olatunde, A., Rahman, M. M., Painuli, S., Semwal, P., Wilairatana, P., & Mubarak, M. S. (2022) · Molecules · doi:10.3390/molecules27103194 · Cited by 316
RetractedNeuroinflammation in Neurodegenerative Disorders-a Review
Schain, M., & Kreisl, W. C. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0733-2 · Cited by 301
Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis
Zhao, W., Beers, D. R., & Appel, S. H. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9489-x · Cited by 309
Werry, E. L., Bright, F., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kril, J. J., & Kassiou, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133161 · Cited by 298
Self-citationProtective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
Hooten, K. G., Beers, D. R., Zhao, W., & Appel, S. H. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0329-3 · Cited by 294
Glial cells in amyotrophic lateral sclerosis
Philips, T., & Rothstein, J. D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.05.015 · Cited by 266
Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes
Chiò, A., Pagani, M., Agosta, F., Calvo, A., Cistaro, A., & Filippi, M. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70167-x · Cited by 253
PET imaging of neuroinflammation in neurological disorders
Kreisl, W. C., Kim, M.-J., Coughlin, J. M., Henter, I. D., Owen, D. R., & Innis, R. B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30346-x · Cited by 254
TDP-43 activates microglia through NF-κB and NLRP3 inflammasome
Zhao, W., Beers, D. R., Bell, S., Wang, J., Wen, S., Baloh, R. H., & Appel, S. H. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.07.019 · Cited by 241
Zürcher, N. R., Loggia, M. L., Lawson, R., Chonde, D. B., Izquierdo-Garcia, D., Yasek, J. E., Akeju, O., Catana, C., Rosen, B. R., Cudkowicz, M. E., et al. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.01.009 · Cited by 226
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
Brites, D. M. T. O., & Vaz, A. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00117 · Cited by 213
Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis
Pagani, M., Chiò, A., Valentini, M. C., Öberg, J., Nobili, F. M., Calvo, A., Moglia, C., Bertuzzo, D., Morbelli, S. D., Carli, F. D., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000792 · Cited by 202
Autophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189
The impact of high and low dose ionising radiation on the central nervous system
Betlazar, C., Middleton, R. J., Banati, R. B., & Liu, G.-J. (2016) · Redox Biology · doi:10.1016/j.redox.2016.08.002 · Cited by 196
Dupont, A.-C., Largeau, B., Santiago Ribeiro, M., Guilloteau, D., Tronel, C., & Arlicot, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040785 · Cited by 182
Self-citationCharacterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes
Zhao, W., Beers, D. R., Hooten, K. G., Sieglaff, D. H., Zhang, A., Sundaram, S. K., Traini, C., Halsey, W. S., Hughes, A. M., Sathe, G. M., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0357 · Cited by 176
Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175
Wong, M., Gertz, B., Chestnut, B. A., & Martin, L. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00279 · Cited by 179
The microglial component of amyotrophic lateral sclerosis
Clarke, B. E., & Patani, R. (2020) · Brain · doi:10.1093/brain/awaa309 · Cited by 164
Quantifying disease progression in amyotrophic lateral sclerosis
Simon, N. G., Turner, M. R., Vucic, S., Al‐Chalabi, A., Shefner, J. M., Lomen, C. E., & Kiernan, M. C. (2014) · Annals of Neurology · doi:10.1002/ana.24273 · Cited by 165
Golla, S. S. V., Boellaard, R., Oikonen, V., Hoffmann, A., van Berckel, B. N. M., Windhorst, A. D., Virta, J. R., Haaparanta‐Solin, M., Luoto, P., Savisto, N., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.261 · Cited by 132
Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125
Lessons of ALS imaging: Pitfalls and future directions — A critical review
Bede, P., & Hardiman, O. M. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.02.011 · Cited by 126
Increased oxidative stress is related to disease severity in the ALS motor cortex
Ikawa, M., Okazawa, H., Tsujikawa, T., Matsunaga, A., Yamamura, O., Mori, T., Hamano, T., Kiyono, Y., Nakamoto, Y., & Yoneda, M. (2015) · Neurology · doi:10.1212/wnl.0000000000001588 · Cited by 120
ALS biomarkers for therapy development: State of the field and future directions
Benatar, M. G., Boylan, K., Jeromin, A., Rutkove, S. B., Berry, J. D., Atassi, N., & Bruijn, L. I. (2015) · Muscle & Nerve · doi:10.1002/mus.24979 · Cited by 116
Baldacci, F., Lista, S., Cavedo, E., Bonuccelli, U., & Hampel, H. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1304217 · Cited by 113
Alam, M. M., Lee, J., & Lee, S. (2017) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-017-0475-8 · Cited by 125
New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases
Scarian, E., Viola, C., Dragoni, F., Gerlando, R. D., Rizzo, B., Diamanti, L., Gagliardi, S., Bordoni, M., & Pansarasa, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052698 · Cited by 118
Mast Cells in Neurodegenerative Disease
Jones, M. K., Nair, A. A., & Gupta, M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00171 · Cited by 107
Mesci, P., Zaïdi, S., Lobsiger, C. S., Millecamps, S., Escartin, C., Seilhean, D., Sato, H., Mallat, M., & Boillée, S. (2014) · Brain · doi:10.1093/brain/awu312 · Cited by 111
Nanoparticles: A Hope for the Treatment of Inflammation in CNS
Zhu, F., Hu, Y.-J., Yu, L., Zhou, X., Wu, J., Tang, Y., Qin, D., Fan, Q., & Wu, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.683935 · Cited by 110
Quek, H., Cuní‐López, C., Stewart, R., Colletti, T., Notaro, A., Sun, Y., Guo, C. C., Lupton, M. K., Nguyen, T. H., Oikari, L. E., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02421-1 · Cited by 108
Radford, R. A. W., Morsch, M., Rayner, S. L., Cole, N. J., Pountney, D. L., & Chung, R. S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00414 · Cited by 105
Alshikho, M. J., Zürcher, N. R., Loggia, M. L., Cernasov, P., Reynolds, B., Pijanowski, O., Chonde, D. B., Izquierdo‐Garcia, D., Mainero, C., Catana, C., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25251 · Cited by 99
Beckers, L., Ory, D., Geric, I., Declercq, L., Koole, M. J. B., Kassiou, M., Bormans, G. M., & Baes, M. I. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1099-1 · Cited by 105
Self-citationCellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
Rizzo, F., Riboldi, G. M., Salani, S., Nizzardo, M., Simone, C., Corti, S. P., & Hedlund, E. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1480-4 · Cited by 93
Clinical and Radiological Markers of Extra-Motor Deficits in Amyotrophic Lateral Sclerosis
Christidi, F., Karavasilis, E., Rentzos, M., Kelekis, N., Evdokimidis, I., & Bede, P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01005 · Cited by 94
Best, L. A., Ghadery, C., Pavese, N., Tai, Y., & Strafella, A. P. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0934-y · Cited by 93
Varley, J. A., Brooks, D. J., & Edison, P. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.08.105 · Cited by 85
NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis Model
Gugliandolo, A., Giacoppo, S., Bramanti, P., & Mazzon, E. (2017) · Inflammation · doi:10.1007/s10753-017-0667-5 · Cited by 79
Katzeff, J. S., Bright, F., Lo, K., Kril, J. J., Connolly, A. M., Crossett, B., Ittner, L. M., Kassiou, M., Loy, C. T., Hodges, J. R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70687-7 · Cited by 77
Self-citationTSPO: kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria
Gatliff, J., & Campanella, M. (2016) · Biochemical Journal · doi:10.1042/bj20150899 · Cited by 79
Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
Filipi, T., Heřmanová, Z., Turečková, J., Vaňátko, O., & Anděrová, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010261 · Cited by 76
Lavisse, S., García-Lorenzo, D., Peyronneau, M., Bodini, B., Thiriez, C., Kühnast, B., Comtat, C., Rémy, P., Stankoff, B., & Bottlaender, M. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.156083 · Cited by 75
CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis
López-López, A., Gámez, J., Syriani, E., Morales, M., Salvadó, M., Rodríguez, M. J., Mahy, N., & Vidal-Taboada, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096528 · Cited by 74
Bede, P., Iyer, P. M., Schuster, C., Elamin, M., McLaughlin, R. L., Kenna, K. P., & Hardiman, O. M. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2016.1173702 · Cited by 74
Masrori, P., Beckers, J., Gossye, H., & Damme, P. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00525-z · Cited by 80
Outcome measures in amyotrophic lateral sclerosis clinical trials
Paganoni, S., Cudkowicz, M., & Berry, J. D. (2014) · Clinical Investigation · doi:10.4155/cli.14.52 · Cited by 70
In vivo PET imaging of neuroinflammation in Alzheimer’s disease
Lagarde, J., Sarazin, M., & Bottlaender, M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1731-x · Cited by 79
Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Haukedal, H., & Freude, K. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.004 · Cited by 68
Brohawn, D. G., O’Brien, L. C., & Bennett, J. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160520 · Cited by 65
Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis
Liu, Z., Cheng, X., Zhong, S., Zhang, X., Liu, C., Liu, F., & Zhao, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00575 · Cited by 68
Hunter, M., Spiller, K. J., Dominique, M. A., Xu, H. W., Hunter, F. W., Fang, T., Canter, R. G., Roberts, C. J., Ransohoff, R. M., Trojanowski, J. Q., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01239-x · Cited by 68
Beers, D. R., Zhao, W., Neal, D. W., Thonhoff, J. R., Thome, A. D., Faridar, A., Wen, S., Wang, J., & Appel, S. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-72247-5 · Cited by 63
Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging
Zhang, J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0236-5 · Cited by 62
TSPO is a REDOX regulator of cell mitophagy
Gatliff, J., & Campanella, M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150037 · Cited by 64
Sabogal-Guáqueta, A. M., Marmolejo-Garza, A., de Pádua, V. P., Eggen, B. J. L., Boddeke, E., & Dolga, A. M. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101805 · Cited by 65
Tiwari, A. K., Ji, B., Yui, J., Fujinaga, M., Yamasaki, T., Xie, L., Luo, R., Shimoda, Y., Kumata, K., Zhang, Y., et al. (2015) · Theranostics · doi:10.7150/thno.12027 · Cited by 59
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
Weehaeghe, D. V., Schoor, E. V., Vocht, J. D., Koole, M. J. B., Attili, B. N. N. R., Celen, S., Declercq, L., Thal, D. R., Damme, P. V., Bormans, G. M., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.231985 · Cited by 58
Zou, J., Tao, S., Johnson, A. S., Tomljanovic, Z., Polly, K., Klein, J., Razlighi, Q. R., Brickman, A. M., Lee, S., Stern, Y., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.019 · Cited by 55
11 C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis
Tondo, G., Iaccarino, L., Cerami, C., Vanoli, G. E., Presotto, L., Masiello, V., Coliva, A., Salvi, F., Bartolomei, I., Mosca, L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51112 · Cited by 56
“Crucially, microglia activation not restricted to brain motor regions, and especially involving temporal regions, has been reported and related to the spread of the neurodegenerative process.(62) However, Figure 4.”
BackgroundCould 18 F-DPA-714 PET imaging be interesting to use in the early post-stroke period?
Ribeiro, M. J., Vercouillie, J., Debiais, S., Cottier, J., Bonnaud, I., Camus, V., Banister, S. D., Kassiou, M., Arlicot, N., & Guilloteau, D. (2014) · EJNMMI Research · doi:10.1186/s13550-014-0028-4 · Cited by 55
Self-citationHigh-Resolution 7T MR Imaging of the Motor Cortex in Amyotrophic Lateral Sclerosis
Cosottini, M., Donatelli, G., Costagli, M., Ienco, E. C., Frosini, D., Pesaresi, I., Biagi, L., Siciliano, G., & Tosetti, M. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4562 · Cited by 55
Weehaeghe, D. V., Ceccarini, J., Delva, A., Robberecht, W., Damme, P. V., & Laere, K. V. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.166272 · Cited by 55
Wang, L., Cheng, R., Fujinaga, M., Yang, J., Zhang, Y., Hatori, A., Kumata, K., Yang, J., Vasdev, N., Du, Y., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00432 · Cited by 58
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact
Marchi, F. D., Munitić, I., Amedei, A., Berry, J. D., Feldman, E. L., Aronica, E., Nardo, G., Weehaeghe, D. V., Niccolai, E., Prtenjača, N., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.027 · Cited by 52
Ory, D., Planas, A. M., Dresselaers, T., Gsell, W., Postnov, A. A., Celen, S., Casteels, C., Himmelreich, U., Debyser, Z., Laere, K. V., et al. (2015) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2015.06.010 · Cited by 53
Glial biomarkers in human central nervous system disease
Garden, G. A., & Campbell, B. M. (2016) · Glia · doi:10.1002/glia.22998 · Cited by 59
PET Radioligands for In Vivo Visualization of Neuroinflammation
Ory, D., Celen, S., Verbruggen, A., & Bormans, G. M. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140613120212 · Cited by 53
Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis
Xiong, L., McCoy, M. G., Komuro, H., West, X. Z., Yakubenko, V. P., Gao, D., Dudiki, T., Milo, A., Chen, J. M., Podrez, E. A., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.11.031 · Cited by 51
Amyloid load and translocator protein 18 kDa in APPswePS1-dE9 mice: a longitudinal study
Sérrière, S., Tauber, C., Vercouillie, J., Mothes, C., Pruckner, C., Guilloteau, D., Kassiou, M., Doméné, A., Garreau, L., Page, G., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.11.023 · Cited by 51
Self-citationPagani, M., Öberg, J., Carli, F. D., Calvo, A., Moglia, C., Canosa, A., Nobili, F. M., Morbelli, S. D., Fania, P., Cistaro, A., et al. (2015) · Human Brain Mapping · doi:10.1002/hbm.23078 · Cited by 48
Gargiulo, S., Anzilotti, S., Coda, A. R. D., Gramanzini, M., Greco, A., Panico, M., Vinciguerra, A., Zannetti, A., Vicidomini, C., Dollé, F., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3311-y · Cited by 48
García-Lorenzo, D., Lavisse, S., Leroy, C., Wimberley, C., Bodini, B., Rémy, P., Veronese, M., Turkheimer, F., Stankoff, B., & Bottlaender, M. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17692599 · Cited by 52
Kinetic modeling and parameter estimation of TSPO PET imaging in the human brain
Wimberley, C., Lavisse, S., Hillmer, A. T., Hinz, R., Turkheimer, F., & Zanotti‐Fregonara, P. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05248-9 · Cited by 52
Chauveau, F., Becker, G., & Boutin, H. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05425-w · Cited by 54
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis
Marini, C., Cistaro, A., Campi, C., Calvo, A., Caponnetto, C., Nobili, F. M., Fania, P., Beltrametti, M. C., Moglia, C., Novi, G., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3440-3 · Cited by 47
Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts
Albrecht, D., Normandin, M. D., Shcherbinin, S., Wooten, D., Schwarz, A. J., Zürcher, N. R., Barth, V., Guehl, N. J., Akeju, O., Atassi, N., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178335 · Cited by 50
Ikawa, M., Okazawa, H., Nakamoto, Y., & Yoneda, M. (2020) · Antioxidants · doi:10.3390/antiox9090861 · Cited by 48
Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design
Fournier, C. N. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01271-2 · Cited by 45
Varghese, A. M., Ghosh, M., Bhagat, S. K., Vijayalakshmi, K., Preethish‐Kumar, V., Vengalil, S., Pradeep-Chandra-Reddy, C., Nashi, S., Polavarapu, K., Sharma, M., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01909-y · Cited by 47
Sensory Involvement in Amyotrophic Lateral Sclerosis
Rubio, M. Á., Herrando‐Grabulosa, M., & Navarro, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415521 · Cited by 48
Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis
Chew, S., & Atassi, N. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00135 · Cited by 43
Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?
Guidotti, G., Scarlata, C., Brambilla, L., & Rossi, D. (2021) · Cells · doi:10.3390/cells10030518 · Cited by 42
Christoforidou, E., Joilin, G., & Hafezparast, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01822-4 · Cited by 44
Médran‐Navarrete, V., Damont, A., Peyronneau, M., Kühnast, B., Bernards, N., Pottier, G., Marguet, F., Puech, F., Boisgard, R., & Dollé, F. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.01.080 · Cited by 43
Boll, M., Bayliss, L., Vargas‐Cañas, S., Burgos, J., Montes, S., Peñaloza-Solano, G., Rı́os, C., & Alcaraz-Zubeldia, M. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.03.005 · Cited by 41
Pradat, P., & Mendili, M. E. (2014) · BioMed Research International · doi:10.1155/2014/467560 · Cited by 41
Tripathi, S., Shree, B., Mohapatra, S., Swati, S., Basu, A., & Sharma, V. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02268-8 · Cited by 43
UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort
Vidal-Taboada, J. M., López-López, A., Salvadó, M., Lorenzo-Sanz, L., García, C. B., Mahy, N., Rodríguez, M. J., & Gámez, J. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7843-z · Cited by 40
Frontotemporal Pathology in Motor Neuron Disease Phenotypes: Insights From Neuroimaging
McKenna, M. C., Corcia, P., Couratier, P., Siah, W. F., Pradat, P., & Bede, P. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.723450 · Cited by 40
Self-citationWang, H., Liu, S., Sun, Y., Chen, C., Hu, Z., Li, Q., Long, J., Yan, Q., Liang, J., Lin, Y., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102472 · Cited by 39
Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia
Kreisl, W. C., Henter, I. D., & Innis, R. B. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.08.004 · Cited by 41
The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond
Gaur, N., Perner, C., Witte, O. W., & Großkreutz, J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00377 · Cited by 40
Imaging of glia activation in people with primary lateral sclerosis
Paganoni, S., Alshikho, M. J., Zürcher, N. R., Cernasov, P., Babu, S., Loggia, M. L., Chan, J. G. M., Chonde, D. B., Izquierdo‐Garcia, D., Catana, C., et al. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.10.024 · Cited by 36
The MicroRNA Centrism in the Orchestration of Neuroinflammation in Neurodegenerative Diseases
Nuzziello, N., & Liguori, M. (2019) · Cells · doi:10.3390/cells8101193 · Cited by 36
Metadata
- Authors
- Corcia, P., Tauber, C., Vercoullie, J., Arlicot, N., Prunier, C., Praline, J., Nicolas, G., Venel, Y., Hommet, C., Baulieu, J.-L., Cottier, J.-P., Roussel, C., Kassiou, M., Guilloteau, D., & Ribeiro, M.-J.
- Affiliations
- Université de Tours (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Centre Hospitalier Universitaire d'Angers (FR)
- Corresponding author
- Corcia, Philippe
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-31
- Volume
- 7
- Issue
- 12
- Pages
- e52941
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3534121
- OpenAlex
- W2051387942
- Cited by
- 249
- References
- 42
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 8 · 2023: 13 · 2022: 19 · 2021: 28 · 2020: 28 · 2019: 20 · 2018: 13 · 2017: 21 · 2016: 23 · 2015: 23 · 2014: 25 · 2013: 6
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
- Funders
- FP7 Health (FP7/2007-2013)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- amyotrophic lateral sclerosis, microglial activation, neuroinflammation, translocator protein (TSPO), [18F]DPA-714, positron emission tomography, distribution volume ratio, cerebral cortex, primary motor cortex, supplementary motor area, temporal cortex, biomarkers
- MeSH terms
- Aged, Amyotrophic Lateral Sclerosis, Brain, Female, Humans, Inflammation, Male, Middle Aged, Radionuclide Imaging, Microglia, Receptors, GABA, Molecular Imaging, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
